2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, G; Carrier, JC; Giroux, V | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and transforming growth factor beta
| Article | Year |
|---|---|
Chemopreventive effect of ERĪ²-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.
Topics: Adenomatous Polyposis Coli Protein; Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Nucleus; Cell Proliferation; Colon; Epithelium; Estrogen Receptor beta; Female; Gene Expression; In Situ Nick-End Labeling; Injections, Subcutaneous; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitriles; Phosphorylation; Propionates; Reverse Transcriptase Polymerase Chain Reaction; Smad2 Protein; Transforming Growth Factor beta | 2011 |